Dr. Alison J. Moskowitz

Dr. Alison J. Moskowitz, MD, is a hematologist-oncologist specializing in lymphoma at Memorial Sloan Kettering Cancer Center (MSK), where she has practiced for more than 11 years. Her clinical focus centers on Hodgkin lymphoma, systemic T cell lymphoma, and cutaneous T cell lymphoma, a rare form of skin lymphoma. She practices as part of a dedicated team of lymphoma experts committed to delivering world-class care while advancing the science of treatment for these diseases.

Dr. Moskowitz is deeply engaged in clinical research aimed at improving outcomes and quality of life for patients with lymphoma. In Hodgkin lymphoma, a disease that is relatively rare but often curable with modern treatment, her work involves incorporating newer drugs into standard regimens to study patient tolerability and reduce the long-term toxic effects of therapy. In T cell lymphoma, which is rare and can be particularly difficult to treat, she leads and participates in clinical trials testing targeted therapies and immunotherapies with the goals of better disease control, improved quality of life, and increased chances of cure.

Patient-centered care is a defining aspect of Dr. Moskowitz's approach to medicine. When meeting with patients for the first time, she prioritizes ensuring they leave with a clear understanding of their diagnosis, their treatment options, and the full range of supportive resources available at MSK. She works alongside a team of nurses, social workers, and clinical assistants who foster a comforting environment for patients navigating a cancer diagnosis. Understanding how frightening a cancer diagnosis can be, she is committed to easing that experience and helping patients feel as well as possible throughout their treatment.